Search

everythinglearnresearchcommunity

for

Search:↓

An 8-year-old girl has a rare, irreversible hair loss condition caused by a genetic mutation.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The study found that males with KFSD had severe skin and eye symptoms, while female carriers had milder symptoms.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

A new type of hereditary hair loss in a Chinese family is linked to chromosome 2p25.1–2p23.2.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Facial hair loss and psychosocial issues are crucial in deciding treatment for alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Alopecia areata causes negative emotions and stress due to hair loss and emotional triggers.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Hodgkin's lymphoma can show up as hair loss.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.